Quantitative DNA Methylation Imaging of Cells and Tissues
AssigneeEpilumina, Inc.
InventorsJian TAJBAKHSH, Daniel L. FARKAS
Life of this patent
Estimating the term…
Loading patent…
AssigneeEpilumina, Inc.
InventorsJian TAJBAKHSH, Daniel L. FARKAS
Estimating the term…
The invention is a method using immunofluorescence, high-resolution imaging, and 3D image analysis to quantify spatial distribution of methylcytosine (MeC) in global DNA in individual cell nuclei, for the characterization of cells and tissues based on their nuclear MeC distribution patterns. The invented method is intended for basic research, clinical diagnostics and prognostics, pharmacology and toxicology, and molecular and cell-based therapy. We describe an image-cytometrical tool performing rapid cell-by-cell assay to analyze the impact of environmental conditions on global DNA methylation, including alterations of methylcytosine load and the spatial reorganization of methylated DNA in cell nuclei. The assay can be combined with molecular approaches for profiling of cells and their genomes. In contrast to molecular methods, it provides information regarding the location of MeC in cell nuclei. The resulting assay can analyze thousands of cells in parallel in a cost-effective manner—currently not possible with molecular methods.
A nondestructive in situ method that entails the quantitative measurement of cytosine methylation (load and spatial distribution) in single cell nuclei, for the characterization of cells and tissues for various applications (including but not restricted to basic research, clinical diagnostics and prognostics, pharmacology and toxicology, and molecular and cell-based therapy), comprising steps of:
Dependencies are inferred from the claim text.